Herbs (Global Traditional) · Ayurveda
Kakmachi (Solanum nigrum) (Solanum nigrum)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Kakmachi (Solanum nigrum) contains bioactive alkaloids solasonine and solamargine that demonstrate hepatoprotective and anti-cancer properties. Preclinical studies show it can reduce liver enzyme elevation by up to 45% in toxin-induced liver injury models.
Kakmachi (Solanum nigrum), commonly known as black nightshade, is an annual herbaceous plant native to Eurasia and widely naturalized globally, particularly valued in Indian Ayurvedic medicine. The plant belongs to the Solanaceae family, with leaves, berries, and whole plant parts harvested fresh or dried for medicinal use, traditionally prepared by simmering in ghee or powdering.
No human clinical trials, RCTs, or meta-analyses have been conducted on Kakmachi according to the available research. Evidence is limited to preclinical rodent models and in vitro cell line studies, with no PubMed PMIDs for human trials identified in the current literature review.
No clinically studied dosage ranges for humans have been established. Traditional Ayurvedic preparations involve whole plant powder or extracts simmered in ghee, but specific standardization or quantitative doses are not detailed in the research. Consult a healthcare provider before starting any new supplement.
Per 100g of fresh Kakmachi (Solanum nigrum) leaves and berries: **Macronutrients:** Moisture 82–87%, Protein 3.2–5.9g, Fat 0.7–1.0g, Carbohydrates 6.0–8.5g, Dietary fiber 1.5–2.8g, Energy ~40–55 kcal. **Minerals:** Calcium 210–410mg, Iron 3.1–10.2mg, Phosphorus 38–70mg, Potassium 350–460mg, Magnesium 52–74mg, Zinc 0.9–1.7mg, Manganese 0.8–1.4mg. Iron is predominantly non-heme with estimated bioavailability of 5–12%, enhanced by co-present ascorbic acid. **Vitamins:** Vitamin C (ascorbic acid) 11–38mg (variable by maturity and preparation; significant losses of 40–60% upon boiling), Vitamin A (as beta-carotene equivalents) 2400–3600 IU (retinol activity equivalent ~400–600 µg RAE), Riboflavin (B2) 0.14–0.59mg, Niacin (B3) 0.5–1.1mg, Thiamine (B1) 0.05–0.10mg, Folate approximately 40–60µg. **Key Bioactive Compounds:** Steroidal glycoalkaloids — solasonine (15–35mg/100g dry weight in unripe berries, significantly lower in ripe berries at 1–5mg/100g), solamargine (10–30mg/100g dry weight unripe, 0.5–3mg/100g ripe), and solanine (trace to 8mg/100g); these are the primary pharmacologically active and potentially toxic constituents. **Flavonoids:** Quercetin (8–25mg/100g dry weight), Kaempferol (5–15mg/100g dry weight), Rutin (quercetin-3-O-rutinoside, 12–40mg/100g dry weight) — oral bioavailability of quercetin is generally low (1–5%) but is improved by rutin glycoside hydrolysis in the gut. **Phenolic acids:** Gallic acid (6–18mg/100g dry weight), Caffeic acid (3–10mg/100g dry weight), Chlorogenic acid (5–15mg/100g dry weight). **Polysaccharides:** Water-soluble polysaccharides (~2–4g/100g dry weight), which contribute to reported immunomodulatory and hepatoprotective activity. **Saponins:** Diosgenin-related steroidal saponins (0.5–2.0% dry weight). **Other:** Riboflavin-binding proteins present in seeds; anthocyanins (primarily delphinidin and malvidin glycosides, ~20–80mg/100g dry weight in ripe black berries) contributing antioxidant capacity. **Bioavailability notes:** Glycoalkaloid content is dramatically reduced (50–80% loss) by traditional Ayurvedic preparation methods including boiling, blanching, and cooking with acidic media. Ripe berries contain substantially lower glycoalkaloid concentrations than unripe green berries, which is why Ayurvedic texts specify use of mature/ripe fruits. Fat-soluble carotenoids have improved bioavailability when consumed with dietary fat. The high oxalate content (approximately 90–120mg/100g fresh leaves) may reduce calcium bioavailability by 20–40% unless leaves are boiled and water discarded.
Kakmachi's hepatoprotective effects occur through solasonine and solamargine alkaloids that modulate cytochrome P450 enzymes and reduce oxidative stress markers. These compounds activate antioxidant pathways including glutathione peroxidase and superoxide dismutase while inhibiting inflammatory cytokines TNF-α and IL-6. The anti-cancer activity involves apoptosis induction through mitochondrial membrane disruption and caspase activation.
Current evidence is limited to preclinical studies, with no published human clinical trials available. Rodent studies using 200-400mg/kg body weight showed significant reductions in ALT and AST liver enzymes within 7-14 days of treatment. In vitro cancer cell studies demonstrate IC50 values of 15-30μg/mL for solasonine against various cancer lines. Human studies are needed to establish safety and efficacy profiles.
Kakmachi contains potentially toxic alkaloids and should be avoided during pregnancy and breastfeeding due to insufficient safety data. May interact with liver-metabolized medications by affecting cytochrome P450 enzymes. High doses can cause gastrointestinal upset, dizziness, and potential liver toxicity. Consultation with healthcare providers is essential before use, especially for individuals with liver conditions.
